This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Revascularization  • Neurology  • Cerebrovascular Disease  • Stroke  • Patient Safety/ Medical Error  • Vascular Surgery  • Prognosis/ Outcomes  • Alert me on articles by topic

Bruce A. Perler, MD, MBA

Arch Surg. 2008;143(8):742.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

During the next 15 years, the number of individuals older than 65 years will increase by 50% and, during the next 40 years, that group will grow by 135%. The most rapid increase will be among our oldest elderly, those older than 75 years. Furthermore, individuals older than 75 years have 5 to 6 times the stroke incidence of younger adults. Selecting the most appropriate treatment of carotid disease in this demographic group is a critically important health care issue.

Because NASCET¹ and ACAS² excluded elderly individuals from randomization, it has been assumed over the years by some, and in particular today by advocates of CAS, that elderly patients a priori are at increased risk of CEA complications and perhaps would be better served by CAS. The report by Suliman et al adds to a voluminous literature published during the past 20 years refuting that . . . [Full Text of this Article]

AUTHOR INFORMATION

RELATED ARTICLE

Carotid Endarterectomy as the Criterion Standard in High-Risk Elderly Patients
Ahmed Suliman, Joshua Greenberg, Ankur Chandra, Samuel Barillas, Pooya Iranpour, and Niren Angle
Arch Surg. 2008;143(8):736-742.
ABSTRACT | FULL TEXT